DermBiont Announces Positive Phase 2 Clinical Trial Data Treating Seborrheic Keratosis Dermbiont Jun 27 Written by Omar Sebai BusinessWire Omar Sebai Previous Previous Vibrant Planet raises $17M seed round to grow forest restoration SaaS Next Next Meet Valia, an early-stage VC firm backed by Tiger that wants to back founders who are ‘breaking the mold’
DermBiont Announces Positive Phase 2 Clinical Trial Data Treating Seborrheic Keratosis Dermbiont Jun 27 Written by Omar Sebai BusinessWire Omar Sebai
